Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
Study Details
Study Description
Brief Summary
This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
|
Detailed Description
PRIMARY OBJECTIVE:
- To assess post-treatment related health state utilities among patients with rectal cancer after treatment at 2 years.
SECONDARY OBJECTIVES:
-
To longitudinally compare the effects of treatment on quality of life and utilities among patients treated with or without (neo)adjuvant radiation therapy.
-
To characterize the impact of treatment on quality of life and utilities among patients with rectal cancer.
-
To assess changes in quality of life and utilities among patients treated for rectal cancer over time.
OUTLINE:
Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Observational (questionnaire) Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery. |
Other: Quality-of-Life Assessment
Complete quality of life questionnaire
Other Names:
Other: Questionnaire Administration
Complete quality of life questionnaire
|
Outcome Measures
Primary Outcome Measures
- Health state utilities [At 24 months post-surgery]
A health state utility is the degree of preference that individuals or society has for a particular health state or condition.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment
-
Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English
Exclusion Criteria:
-
Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer
-
Patient has a concurrent cancer diagnosis at the time of consent
-
Patient has recurrent disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | M D Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- M.D. Anderson Cancer Center
Investigators
- Principal Investigator: George J Chang, M.D. Anderson Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2013-0631
- NCI-2020-07835
- 2013-0631
- K07CA133187